Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Bergentoft Pharma Consulting AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 6 More Arrow 2,010 Less Arrow 1,943
Financial expenses 15 Less Arrow 8 Less Arrow 0
Earnings before taxes -81 More Arrow 1,757 Less Arrow 1,198
EBITDA -167 More Arrow 1,740 Less Arrow 1,198
Total assets 3,273 More Arrow 4,031 Less Arrow 2,779
Current assets 2,129 More Arrow 3,063 Less Arrow 1,833
Current liabilities 108 More Arrow 634 More Arrow 725
Equity capital 2,914 More Arrow 3,143 Less Arrow 1,909
- share capital 52 Less Arrow 51 Less Arrow 47
Employees (average) 1 More Arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 89.0% Less Arrow 78.0% Less Arrow 68.7%
Turnover per employee 6 More Arrow 1,005 More Arrow 1,943
Profit as a percentage of turnover -1350.0% More Arrow 87.4% Less Arrow 61.7%
Return on assets (ROA) -2.0% More Arrow 43.8% Less Arrow 43.1%
Current ratio 1971.3% Less Arrow 483.1% Less Arrow 252.8%
Return on equity (ROE) -2.8% More Arrow 55.9% More Arrow 62.8%
Change turnover -2,040 More Arrow -71 More Arrow 831
Change turnover % -100% More Arrow -3% More Arrow 75%
Chg. No. of employees -1 More Arrow 1 Less Arrow 0
Chg. No. of employees % -50% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.